Skip to main content
. 2016 Aug 19;14(4):3206–3214. doi: 10.3892/mmr.2016.5657

Figure 1.

Figure 1

Experimental protocols and inhibition of DNCB-induced AD progression by topical application of AAFE in BALB/c mice. (A) Experimental schedule for the induction of AD-like skin lesions and oral administration of AAFE. (B) Representative images of the ear skin from each group are shown. DNCB, 2,4-dinitrochlorobenzene; AD, atopic dermatitis; AAFE, Artemisia argyi Folium extract.